Norio Hamamatsu, PhDSenior Director at RevolKa Ltd.
Profile
Norio Hamamatsu is Senior Director and Head of US office at RevolKa Ltd. Before joining RevolKa, Norio was a principal scientist at Novartis Institutes for Biomedical Research, Inc., and led multiple biologics projects of both antibody and protein therapeutics. He graduated from Kyoto University and received his Ph.D. from Saitama University, where his research focused on protein engineering and directed evolution of proteins. He reported unique methods to explore protein fitness landscapes.
Agenda Sessions
Therapeutic Antibody Engineering for Highly Stable Formulations by Using a Machine Learning-guided Protein Engineering Technique, aiProteinĀ®
,Ā 1:45pmView Session